CDK4 and colorectal carcinoma: A randomized controlled trial also revealed that oral supplementation of RS for 4 weeks in patients with CRC reduced the cell cycle regulatory genes CDK4 and GADD45A, inhibiting cell proliferation in the upper part of colonic crypts [24].